GRANT PROGRAM DESCRIPTION

The AACT is offering a research grant program that supports clinical toxicology research and the development of new investigators' research skills. Applications for this research grant program should emphasize study objectives that focus on clinical toxicology research, sound research methods that support the study objectives, interdisciplinary collaborations, the potential for the project to be replicated, and prudent use of grant funds. The mentoring of new researchers by more experienced senior investigators is a key aspect of this program. Multidisciplinary research teams are encouraged.

ELIGIBILITY

  • The research must focus on clinical toxicology research.
  • The junior (principal) and senior investigators must be members of the American Academy of Clinical Toxicology in good standing.
  • The principal investigator must be a new researcher within 5 years of completion of his/her terminal degree and any subsequent postgraduate training (i.e. postdoctoral fellowship or residency) or have professional experience greater than 5 years and no more than two externally funded research projects as a principal investigator. Also, the principal investigator must have a senior investigator participate on the research team as a mentor/advisor. In the application process and grant progress reports, evidence must be included regarding the support and involvement of the senior investigator. Toxicology fellows in the last year of their fellowship are eligible recipients, but in such case, funding will go to the institution at which the fellow will become employed. Evidence of support from that institution and a senior investigator from that institution must be provided in the application.
  • The study timeline should not exceed 24 months from project initiation.

 FUNDING INFORMATION 

One $45,000 grant will be awarded every other year. Grants are awarded to provide funding for specific projects conducted by junior investigator and senior investigator research teams that address clinical toxicology research and are not intended for long-term support of research programs.

Funds may not be applied to: 

  • Ongoing general operating expenses or existing deficits
  • Purchase of equipment, facilities, software, or other capital costs
  • Facilities and administrative (institutional indirect) costs

Funds may not be applied to:

  • Ongoing general operating expenses or existing deficits
  • Purchase of equipment, facilities, software, or other capital costs
  • Facilities and administrative (institutional indirect) costs

Funding is generally available for: 

  • Salary support for study personnel
  • Consumable supplies and services
  • Travel essential to the conduct of the proposed project or to present research results
  • Subject expenses/reimbursement

GRANT RECIPIENT RESPONSIBILITIES

  • The AACT requires that the findings of the funded study be submitted for presentation at a national or international scientific meeting. The North American Congress of Clinical Toxicology retains the right of first refusal for presentation of all findings that emanate from this AACT-sponsored research.
  • Within 6 months of submission of the Final Research Report, the findings of the study must be submitted to a peer-reviewed journal for publication.Clinical Toxicology retains the right of first refusal for publication of all findings that emanate from this AACT-sponsored research.
  • By accepting this award, the grantee will undertake all reasonable efforts to complete the study and take responsibility for fulfilling the terms described within the award letter.

TO APPLY

This award will be granted again in May of 2026. Application details will be distributed closer to date.

JrInvestigator_Application PDF version for Sections 7-9 (to be uploaded to online application)